Pub Date : 2026-03-01Epub Date: 2025-11-07DOI: 10.1016/j.bpsgos.2025.100651
Huanqing Yang , Sowmya Narayan , Joeri Bordes , Lotte van Doeselaar , Carlo De Donno , Matthias Eder , Danusa Menegaz , Rosa-Eva Huettl , Lea-Maria Brix , Shiladitya Mitra , Margherita Springer , Marianne B. Müller , Alon Chen , Jan M. Deussing , Juan Pablo Lopez , Mathias V. Schmidt
Background
Exposure to stressful life events is a major risk factor for many psychiatric disorders. The mineralocorticoid receptor (MR) is a key regulator of the hypothalamic-pituitary-adrenal axis, a central stress response component. Stress-related mental disorders, such as anxiety and depression, are associated with MR dysfunction in the brain, but its cell type–specific contributions to emotional behavior and cognitive function remain unclear.
Methods
Using a mouse model with a specific deletion of MR in forebrain glutamatergic neurons, we tested the behavioral, structural, and functional impact of MR in this neuronal population (n = 9–14 for behavioral and n = 3–4 for structural and functional analyses).
Results
We revealed a specific function of MR in regulating baseline anxiety in male but not female mice. This distinct behavioral phenotype was associated with hippocampal structural and functional alterations. Furthermore, we identified a previously unrecognized downstream target of MR, the actin-bundling factor Fam107a, whose expression is tightly regulated by MR. Overexpression of Fam107a in the hippocampus was sufficient to rescue the increased anxiety phenotype of glutamatergic MR knockout mice.
Conclusions
Together, our results underline the central role of MR as a potential target in understanding the intricate interplay between stress, resilience, and mental health.
暴露于压力生活事件是许多精神疾病的主要危险因素。矿化皮质激素受体(MR)是下丘脑-垂体-肾上腺轴的关键调节因子,是应激反应的中心成分。与压力相关的精神障碍,如焦虑和抑郁,与大脑的核磁共振功能障碍有关,但其细胞类型特异性对情绪行为和认知功能的贡献尚不清楚。方法使用前脑谷氨酸能神经元特异性MR缺失的小鼠模型,我们测试了MR对该神经元群体的行为、结构和功能影响(n = 9-14, n = 3-4)。结果我们发现MR在雄性小鼠而非雌性小鼠中具有调节基线焦虑的特定功能。这种独特的行为表型与海马结构和功能改变有关。此外,我们发现了一个以前未被识别的MR下游靶点,即肌动蛋白捆绑因子Fam107a,其表达受到MR的严格调控,在海马中过度表达Fam107a足以挽救谷氨酸能MR敲除小鼠增加的焦虑表型。总之,我们的研究结果强调了MR在理解压力、恢复力和心理健康之间错综复杂的相互作用方面的核心作用。
{"title":"Mineralocorticoid Receptor in Glutamatergic Neurons Modulates Anxiety Exclusively in Male Mice Via Regulation of the Actin-Bundling Factor Fam107a","authors":"Huanqing Yang , Sowmya Narayan , Joeri Bordes , Lotte van Doeselaar , Carlo De Donno , Matthias Eder , Danusa Menegaz , Rosa-Eva Huettl , Lea-Maria Brix , Shiladitya Mitra , Margherita Springer , Marianne B. Müller , Alon Chen , Jan M. Deussing , Juan Pablo Lopez , Mathias V. Schmidt","doi":"10.1016/j.bpsgos.2025.100651","DOIUrl":"10.1016/j.bpsgos.2025.100651","url":null,"abstract":"<div><h3>Background</h3><div>Exposure to stressful life events is a major risk factor for many psychiatric disorders. The mineralocorticoid receptor (MR) is a key regulator of the hypothalamic-pituitary-adrenal axis, a central stress response component. Stress-related mental disorders, such as anxiety and depression, are associated with MR dysfunction in the brain, but its cell type–specific contributions to emotional behavior and cognitive function remain unclear.</div></div><div><h3>Methods</h3><div>Using a mouse model with a specific deletion of MR in forebrain glutamatergic neurons, we tested the behavioral, structural, and functional impact of MR in this neuronal population (<em>n</em> = 9–14 for behavioral and <em>n</em> = 3–4 for structural and functional analyses).</div></div><div><h3>Results</h3><div>We revealed a specific function of MR in regulating baseline anxiety in male but not female mice. This distinct behavioral phenotype was associated with hippocampal structural and functional alterations. Furthermore, we identified a previously unrecognized downstream target of MR, the actin-bundling factor Fam107a, whose expression is tightly regulated by MR. Overexpression of Fam107a in the hippocampus was sufficient to rescue the increased anxiety phenotype of glutamatergic MR knockout mice.</div></div><div><h3>Conclusions</h3><div>Together, our results underline the central role of MR as a potential target in understanding the intricate interplay between stress, resilience, and mental health.</div></div>","PeriodicalId":72373,"journal":{"name":"Biological psychiatry global open science","volume":"6 2","pages":"Article 100651"},"PeriodicalIF":3.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145885178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-11-01DOI: 10.1016/j.bpsgos.2025.100650
Gerardo Mendez-Victoriano , Yunting Zhu , Layla Neuhaus , Suhaana Shaik , Frank Middleton , Yuji Kondo , Amir Fayyazuddin , Daniel Hoeppner , Sofía Puvogel , Astrid Alsema , Laura Kracht , Mitsuyuki Matsumoto , Bart J.L. Eggen , Adam K. Walker , Maree J. Webster , Iris E.C. Sommer , Cynthia S. Weickert
Background
Neuroinflammation is a key neuropathological finding in schizophrenia and bipolar disorder, as increased cytokines are found in the midbrain of these individuals. However, the most upregulated inflammatory cytokines and most activated downstream signaling pathway(s) are unidentified.
Methods
We aimed to identify the most robust transcriptional change in the schizophrenia midbrain by bulk RNA sequencing (RNA-seq) and to confirm the cellular source and magnitude of change by single-nucleus RNA-seq, reverse transcriptase–polymerase chain reaction (RT-PCR), and immunohistochemistry in 61 healthy controls, 63 schizophrenia cases, and 33 bipolar disorder cases stratified into low- and high-inflammation groups.
Results
By RNA-seq, the TNF superfamily (TNFSF) pathway messenger RNAs (mRNAs) were among the most changed in high-inflammation schizophrenia (all ps ≤ .01), with TNFSF receptors (TNFR1, TNFR2, and FAS) being most highly expressed in astrocytes and microglia. Using RT-PCR, we confirmed that 5 TNFSF receptor mRNAs (TNFR1, TNFR2, DR4, FAS, and TWEAKR, all ps ≤ .01) were increased in high-inflammation schizophrenia/bipolar disorder cases compared with low-inflammation controls. Furthermore, the means for mRNA encoding cell death–related proteins acting downstream of TNF receptors (P53, CASP1, CASP7, CASP8; all ps ≤ .05) were increased in high-inflammation schizophrenia, as were mRNAs encoding proteins regulating cell survival (BCL2 and MCL1, all ps ≤ .01). All 5 TNFSF receptor mRNAs positively correlated with effector protein mRNAs (all ps ≤ .05) and with the astrocyte-related marker GFAP mRNA (all ps ≤ .001).
Conclusions
Our results suggest that TNFSF transcripts represent the main activated inflammatory pathway in the midbrains of people with schizophrenia, which overlaps somewhat with bipolar disorder. These findings highlight the need for anti-inflammatory interventions targeting TNF/TNFSF receptors to test for therapeutic benefits in psychiatric patients displaying elevated inflammation.
{"title":"Increased Tumor Necrosis Factor Superfamily Members in Neuroinflammatory Schizophrenia and Bipolar Disorder Midbrains","authors":"Gerardo Mendez-Victoriano , Yunting Zhu , Layla Neuhaus , Suhaana Shaik , Frank Middleton , Yuji Kondo , Amir Fayyazuddin , Daniel Hoeppner , Sofía Puvogel , Astrid Alsema , Laura Kracht , Mitsuyuki Matsumoto , Bart J.L. Eggen , Adam K. Walker , Maree J. Webster , Iris E.C. Sommer , Cynthia S. Weickert","doi":"10.1016/j.bpsgos.2025.100650","DOIUrl":"10.1016/j.bpsgos.2025.100650","url":null,"abstract":"<div><h3>Background</h3><div>Neuroinflammation is a key neuropathological finding in schizophrenia and bipolar disorder, as increased cytokines are found in the midbrain of these individuals. However, the most upregulated inflammatory cytokines and most activated downstream signaling pathway(s) are unidentified.</div></div><div><h3>Methods</h3><div>We aimed to identify the most robust transcriptional change in the schizophrenia midbrain by bulk RNA sequencing (RNA-seq) and to confirm the cellular source and magnitude of change by single-nucleus RNA-seq, reverse transcriptase–polymerase chain reaction (RT-PCR), and immunohistochemistry in 61 healthy controls, 63 schizophrenia cases, and 33 bipolar disorder cases stratified into low- and high-inflammation groups.</div></div><div><h3>Results</h3><div>By RNA-seq, the TNF superfamily (TNFSF) pathway messenger RNAs (mRNAs) were among the most changed in high-inflammation schizophrenia (all <em>p</em>s ≤ .01), with TNFSF receptors (<em>TNFR1</em>, <em>TNFR2</em>, and <em>FAS</em>) being most highly expressed in astrocytes and microglia. Using RT-PCR, we confirmed that 5 TNFSF receptor mRNAs (<em>TNFR</em><em>1</em>, <em>TNFR</em><em>2</em>, <em>DR4</em>, <em>FAS</em>, and <em>TWEAKR</em>, all <em>p</em>s ≤ .01) were increased in high-inflammation schizophrenia/bipolar disorder cases compared with low-inflammation controls. Furthermore, the means for mRNA encoding cell death–related proteins acting downstream of TNF receptors (<em>P53</em>, <em>CASP1</em>, <em>CASP7</em>, <em>CASP8</em>; all <em>p</em>s ≤ .05) were increased in high-inflammation schizophrenia, as were mRNAs encoding proteins regulating cell survival (<em>BCL2</em> and <em>MCL1</em>, all <em>p</em>s ≤ .01). All 5 TNFSF receptor mRNAs positively correlated with effector protein mRNAs (all <em>p</em>s ≤ .05) and with the astrocyte-related marker <em>GFAP</em> mRNA (all <em>p</em>s ≤ .001).</div></div><div><h3>Conclusions</h3><div>Our results suggest that TNFSF transcripts represent the main activated inflammatory pathway in the midbrains of people with schizophrenia, which overlaps somewhat with bipolar disorder. These findings highlight the need for anti-inflammatory interventions targeting TNF/TNFSF receptors to test for therapeutic benefits in psychiatric patients displaying elevated inflammation.</div></div>","PeriodicalId":72373,"journal":{"name":"Biological psychiatry global open science","volume":"6 2","pages":"Article 100650"},"PeriodicalIF":3.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145939220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-10-31DOI: 10.1016/j.bpsgos.2025.100649
Sara Jani , Stefanie Hassel , Jane A. Foster , Gustavo Turecki , Nicholas Bock , Nathan Churchill , Daniel J. Mueller , Raymond W. Lam , Valerie H. Taylor , Roumen Milev , Claudio Soares , Susan Rotzinger , Sakina J. Rizvi , Sidney H. Kennedy , Benicio N. Frey , Katharine Dunlop
Background
Major depressive disorder (MDD) is a common condition with heterogeneous risk factors. Socioeconomic status (SES) is one such risk factor, which is negatively linked to MDD treatment outcomes and symptom severity. SES is associated with altered resting-state functional connectivity (RSFC) in reward-processing circuitry and elevated proinflammatory cytokine levels in individuals without depression. However, how the negative consequences of low SES exacerbate MDD psychopathology is poorly understood.
Methods
Data on SES (household income and education), depression severity, self-reported reward processing, serum proinflammatory cytokine levels, and neuroimaging for 323 adult participants (211 patients with MDD receiving open-label escitalopram, 112 control participants without depression; 63.4% female) were obtained from the CAN-BIND-1 (Canadian Biomarker Integration in Depression Study-1) dataset. General linear models assessed the effects of MDD diagnosis and SES on self-reported reward processing and proinflammatory cytokine levels. Whole-brain seed-to-voxel RSFC analyses were performed for the dorsal and ventral striatum leveraging 249 participants (150 patients with MDD, 99 control participants; 62.2% female). We also assessed the impact of SES on response to open-label escitalopram.
Results
Participants with MDD from households with lower incomes displayed lower goal pursuit behaviors, decreased interleukin 1β levels, and slower improvement to escitalopram relative to those from households with higher incomes. Using a lenient z > 2.3 threshold, MDD household income correlated with striatal RSFC with the dorsolateral prefrontal and posterior cingulate cortices.
Conclusions
Our results elucidate the role of SES and its negative consequences in altering reward processing and antidepressant treatment efficacy in MDD, corroborating previous literature suggesting that SES significantly impacts health outcomes. Better characterizing the relationship between SES and MDD psychopathology may inform future treatment approaches and intervention development.
{"title":"Socioeconomic Status Is Associated With Reward Processing, Interleukin 1β, Striatal Connectivity, and Antidepressant Outcomes in Individuals With Major Depressive Disorder: A CAN-BIND-1 Report","authors":"Sara Jani , Stefanie Hassel , Jane A. Foster , Gustavo Turecki , Nicholas Bock , Nathan Churchill , Daniel J. Mueller , Raymond W. Lam , Valerie H. Taylor , Roumen Milev , Claudio Soares , Susan Rotzinger , Sakina J. Rizvi , Sidney H. Kennedy , Benicio N. Frey , Katharine Dunlop","doi":"10.1016/j.bpsgos.2025.100649","DOIUrl":"10.1016/j.bpsgos.2025.100649","url":null,"abstract":"<div><h3>Background</h3><div>Major depressive disorder (MDD) is a common condition with heterogeneous risk factors. Socioeconomic status (SES) is one such risk factor, which is negatively linked to MDD treatment outcomes and symptom severity. SES is associated with altered resting-state functional connectivity (RSFC) in reward-processing circuitry and elevated proinflammatory cytokine levels in individuals without depression. However, how the negative consequences of low SES exacerbate MDD psychopathology is poorly understood.</div></div><div><h3>Methods</h3><div>Data on SES (household income and education), depression severity, self-reported reward processing, serum proinflammatory cytokine levels, and neuroimaging for 323 adult participants (211 patients with MDD receiving open-label escitalopram, 112 control participants without depression; 63.4% female) were obtained from the CAN-BIND-1 (Canadian Biomarker Integration in Depression Study-1) dataset. General linear models assessed the effects of MDD diagnosis and SES on self-reported reward processing and proinflammatory cytokine levels. Whole-brain seed-to-voxel RSFC analyses were performed for the dorsal and ventral striatum leveraging 249 participants (150 patients with MDD, 99 control participants; 62.2% female). We also assessed the impact of SES on response to open-label escitalopram.</div></div><div><h3>Results</h3><div>Participants with MDD from households with lower incomes displayed lower goal pursuit behaviors, decreased interleukin 1β levels, and slower improvement to escitalopram relative to those from households with higher incomes. Using a lenient <em>z</em> > 2.3 threshold, MDD household income correlated with striatal RSFC with the dorsolateral prefrontal and posterior cingulate cortices.</div></div><div><h3>Conclusions</h3><div>Our results elucidate the role of SES and its negative consequences in altering reward processing and antidepressant treatment efficacy in MDD, corroborating previous literature suggesting that SES significantly impacts health outcomes. Better characterizing the relationship between SES and MDD psychopathology may inform future treatment approaches and intervention development.</div></div>","PeriodicalId":72373,"journal":{"name":"Biological psychiatry global open science","volume":"6 2","pages":"Article 100649"},"PeriodicalIF":3.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145798708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-10-31DOI: 10.1016/j.bpsgos.2025.100647
Eric R. Larson , Natasha Chaku , Alexandra Moussa-Tooks
Background
Puberty has long been identified as a risk factor for psychosis, although retrospective, cross-sectional, and single-sex indicators of puberty have limited our ability to pinpoint biopsychosocial mechanisms contributing to risk. The current study determined whether individual differences in the timing (onset) and tempo (pace) of pubertal development conferred risk for psychotic-like experiences (PLEs) in youth across biological sex.
Methods
Data included 11,758 youths (6134 boys and 5624 girls) from the ABCD (Adolescent Brain Cognitive Development) Study (average age = 9.9 years at baseline, 12.9 years at 3-year follow-up). Pubertal timing and tempo (overall, adrenarche, gonadarche) were derived from sex-specific linear mixed-effects models using the Pubertal Development Scale. Sex-specific negative binomial multilevel models estimated effects of categorical and continuously measured pubertal timing and tempo and their interaction on year-3 PLEs per the Prodromal Questionnaire-Brief Child.
Results
In both sexes, earlier pubertal timing was associated with elevated PLEs (βs = 0.23 to 0.31), and later pubertal timing was associated with fewer PLEs (βs = −0.22 to −0.52) relative to on-time peers. In boys only, faster pubertal tempo was associated with fewer PLEs relative to on-track peers (βs = −0.21 to −0.30). Analyses with continuous pubertal timing and tempo demonstrated an association between earlier adrenarchal timing and more PLEs in girls only (β = −0.21) and an interaction between adrenarchal timing and tempo in boys only (β = −0.80).
Conclusions
Early pubertal timing in both sexes and faster pubertal tempo in males increases PLEs. Understanding the unique experiences associated with a youth’s pubertal maturation, particularly adrenarche, can advance identification and prevention efforts for children and adolescents at greatest clinical risk.
{"title":"Early Pubertal Development Is a Risk Factor for Psychotic-Like Experiences in Boys and Girls","authors":"Eric R. Larson , Natasha Chaku , Alexandra Moussa-Tooks","doi":"10.1016/j.bpsgos.2025.100647","DOIUrl":"10.1016/j.bpsgos.2025.100647","url":null,"abstract":"<div><h3>Background</h3><div>Puberty has long been identified as a risk factor for psychosis, although retrospective, cross-sectional, and single-sex indicators of puberty have limited our ability to pinpoint biopsychosocial mechanisms contributing to risk. The current study determined whether individual differences in the timing (onset) and tempo (pace) of pubertal development conferred risk for psychotic-like experiences (PLEs) in youth across biological sex.</div></div><div><h3>Methods</h3><div>Data included 11,758 youths (6134 boys and 5624 girls) from the ABCD (Adolescent Brain Cognitive Development) Study (average age = 9.9 years at baseline, 12.9 years at 3-year follow-up). Pubertal timing and tempo (overall, adrenarche, gonadarche) were derived from sex-specific linear mixed-effects models using the Pubertal Development Scale. Sex-specific negative binomial multilevel models estimated effects of categorical and continuously measured pubertal timing and tempo and their interaction on year-3 PLEs per the Prodromal Questionnaire-Brief Child.</div></div><div><h3>Results</h3><div>In both sexes, earlier pubertal timing was associated with elevated PLEs (βs = 0.23 to 0.31), and later pubertal timing was associated with fewer PLEs (βs = −0.22 to −0.52) relative to on-time peers. In boys only, faster pubertal tempo was associated with fewer PLEs relative to on-track peers (βs = −0.21 to −0.30). Analyses with continuous pubertal timing and tempo demonstrated an association between earlier adrenarchal timing and more PLEs in girls only (β = −0.21) and an interaction between adrenarchal timing and tempo in boys only (β = −0.80).</div></div><div><h3>Conclusions</h3><div>Early pubertal timing in both sexes and faster pubertal tempo in males increases PLEs. Understanding the unique experiences associated with a youth’s pubertal maturation, particularly adrenarche, can advance identification and prevention efforts for children and adolescents at greatest clinical risk.</div></div>","PeriodicalId":72373,"journal":{"name":"Biological psychiatry global open science","volume":"6 2","pages":"Article 100647"},"PeriodicalIF":3.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145841259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-12-18DOI: 10.1016/j.bpsgos.2025.100678
Danielle M. Adams , Murray J. Cairns
Background
Anorexia nervosa (AN) is an eating disorder with complex biology that remains largely uncharacterized. Recent genome-wide association studies have identified genetic associations between metabolic traits and AN that may relate to the underlying pathophysiology of the condition. Moreover, observational studies have identified evidence of dysregulated metabolic traits in AN, with emerging evidence suggesting that some of these findings are also observed in weight-restored individuals. While there is evidence for putative shared genetic factors linking metabolic traits and AN, the biology underpinning these genetic relationships has not been thoroughly investigated.
Methods
To further explore shared genetic architecture between metabolic traits and AN with regional specificity, we investigated spatially localized genetic correlation and Bayesian colocalization between 6 metabolic traits (body mass index, high-density lipoprotein, leptin, fasting insulin, insulin resistance, and type 2 diabetes) (n = 30,931–659,316) and AN (n = 72,517).
Results
Significant local genetic correlation was identified across 60 regions, between genetic liability to AN and one of the 6 metabolic traits, after Benjamini-Hochberg correction. Three of these regions showed strong evidence of colocalization with a shared variant (posterior probability > 0.8), indicating potential functional mechanisms related to the trait associations for high-density lipoprotein and body mass index.
Conclusions
Using evidence of local genetic correlation and colocalization, we found independent regions of the genome that may determine the genome-wide genetic correlation between metabolic traits and AN and identified specific shared genes which may assist with our mechanistic understanding of the inherent biological link between AN and metabolites.
{"title":"Exploring the Genetic Overlap Between Metabolic Traits and Anorexia Nervosa","authors":"Danielle M. Adams , Murray J. Cairns","doi":"10.1016/j.bpsgos.2025.100678","DOIUrl":"10.1016/j.bpsgos.2025.100678","url":null,"abstract":"<div><h3>Background</h3><div>Anorexia nervosa (AN) is an eating disorder with complex biology that remains largely uncharacterized. Recent genome-wide association studies have identified genetic associations between metabolic traits and AN that may relate to the underlying pathophysiology of the condition. Moreover, observational studies have identified evidence of dysregulated metabolic traits in AN, with emerging evidence suggesting that some of these findings are also observed in weight-restored individuals. While there is evidence for putative shared genetic factors linking metabolic traits and AN, the biology underpinning these genetic relationships has not been thoroughly investigated.</div></div><div><h3>Methods</h3><div>To further explore shared genetic architecture between metabolic traits and AN with regional specificity, we investigated spatially localized genetic correlation and Bayesian colocalization between 6 metabolic traits (body mass index, high-density lipoprotein, leptin, fasting insulin, insulin resistance, and type 2 diabetes) (<em>n</em> = 30,931–659,316) and AN (<em>n</em> = 72,517).</div></div><div><h3>Results</h3><div>Significant local genetic correlation was identified across 60 regions, between genetic liability to AN and one of the 6 metabolic traits, after Benjamini-Hochberg correction. Three of these regions showed strong evidence of colocalization with a shared variant (posterior probability > 0.8), indicating potential functional mechanisms related to the trait associations for high-density lipoprotein and body mass index.</div></div><div><h3>Conclusions</h3><div>Using evidence of local genetic correlation and colocalization, we found independent regions of the genome that may determine the genome-wide genetic correlation between metabolic traits and AN and identified specific shared genes which may assist with our mechanistic understanding of the inherent biological link between AN and metabolites.</div></div>","PeriodicalId":72373,"journal":{"name":"Biological psychiatry global open science","volume":"6 2","pages":"Article 100678"},"PeriodicalIF":3.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146168070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-11-29DOI: 10.1016/j.bpsgos.2025.100660
Nadja R. Ging-Jehli , Rachel Rac-Lubashevsky , Krishn Bera , Megan A. Boudewyn , Cameron S. Carter , Molly A. Erickson , James M. Gold , Steven J. Luck , J. Daniel Ragland , Andrew P. Yonelinas , Angus W. MacDonald III , Deanna M. Barch , Michael J. Frank
Background
Major depressive disorder (MDD), bipolar disorder (BP), and schizophrenia (SCZ) involve learning impairments with poorly understood mechanisms. Understanding both the similarities and differences in these mechanisms is important to guide the development of new, targeted interventions.
Methods
A total of 255 participants diagnosed with MDD (n = 54), BP (n = 47), or SCZ (n = 67) or without any clinical diagnoses (control [CTRL]) (n = 87) performed an associative learning task. Computational modeling quantified the mechanistic interplay between working memory (WM) and reinforcement learning (RL). The latent RL and WM signatures in the electroencephalography (EEG) dynamics showed shared and distinct neurocognitive mechanisms underlying learning.
Results
All clinical groups showed learning impairments at the behavioral level. Model-based EEG analyses linked these impairments to distinct patterns in the dynamic interplay between latent RL and WM mechanisms, contrasting with the typical patterns observed in the CTRL group. SCZ was characterized by reduced neural markers of WM, weakening the cooperative influence of WM onto RL (reduced WM recruitment), and reduced integration of negative feedback. Conversely, MDD was characterized by reduced reciprocal influence of RL onto WM, reducing the tendency to upregulate WM contribution with reward history (impaired WM management). Finally, BP was characterized by deficits in both WM and RL recruitment, along with higher WM decay.
Conclusions
Behavioral learning impairments that seem similar across clinical groups can be linked to distinct neurocognitive mechanisms via integrative neurocomputational modeling. Our approach provides insights into the interplay of underlying learning mechanisms and how they manifest differently across psychopathologies.
{"title":"Model-Based Electroencephalography Phenotyping Uncovers Distinct Neurocomputational Mechanisms Underlying Learning Impairments Across Psychopathologies","authors":"Nadja R. Ging-Jehli , Rachel Rac-Lubashevsky , Krishn Bera , Megan A. Boudewyn , Cameron S. Carter , Molly A. Erickson , James M. Gold , Steven J. Luck , J. Daniel Ragland , Andrew P. Yonelinas , Angus W. MacDonald III , Deanna M. Barch , Michael J. Frank","doi":"10.1016/j.bpsgos.2025.100660","DOIUrl":"10.1016/j.bpsgos.2025.100660","url":null,"abstract":"<div><h3>Background</h3><div>Major depressive disorder (MDD), bipolar disorder (BP), and schizophrenia (SCZ) involve learning impairments with poorly understood mechanisms. Understanding both the similarities and differences in these mechanisms is important to guide the development of new, targeted interventions.</div></div><div><h3>Methods</h3><div>A total of 255 participants diagnosed with MDD (<em>n</em> = 54), BP (<em>n</em> = 47), or SCZ (<em>n</em> = 67) or without any clinical diagnoses (control [CTRL]) (<em>n</em> = 87) performed an associative learning task. Computational modeling quantified the mechanistic interplay between working memory (WM) and reinforcement learning (RL). The latent RL and WM signatures in the electroencephalography (EEG) dynamics showed shared and distinct neurocognitive mechanisms underlying learning.</div></div><div><h3>Results</h3><div>All clinical groups showed learning impairments at the behavioral level. Model-based EEG analyses linked these impairments to distinct patterns in the dynamic interplay between latent RL and WM mechanisms, contrasting with the typical patterns observed in the CTRL group. SCZ was characterized by reduced neural markers of WM, weakening the cooperative influence of WM onto RL (reduced WM recruitment), and reduced integration of negative feedback. Conversely, MDD was characterized by reduced reciprocal influence of RL onto WM, reducing the tendency to upregulate WM contribution with reward history (impaired WM management). Finally, BP was characterized by deficits in both WM and RL recruitment, along with higher WM decay.</div></div><div><h3>Conclusions</h3><div>Behavioral learning impairments that seem similar across clinical groups can be linked to distinct neurocognitive mechanisms via integrative neurocomputational modeling. Our approach provides insights into the interplay of underlying learning mechanisms and how they manifest differently across psychopathologies.</div></div>","PeriodicalId":72373,"journal":{"name":"Biological psychiatry global open science","volume":"6 2","pages":"Article 100660"},"PeriodicalIF":3.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146078099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-11-12DOI: 10.1016/j.bpsgos.2025.100639
Mary M. Torregrossa
{"title":"Harnessing Analysis of Individual Differences in Behavior to Identify Novel Mechanisms Relevant to Neuropsychiatric Disorders","authors":"Mary M. Torregrossa","doi":"10.1016/j.bpsgos.2025.100639","DOIUrl":"10.1016/j.bpsgos.2025.100639","url":null,"abstract":"","PeriodicalId":72373,"journal":{"name":"Biological psychiatry global open science","volume":"6 1","pages":"Article 100639"},"PeriodicalIF":3.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145520846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-09-26DOI: 10.1016/j.bpsgos.2025.100620
Cassandra E. Hartsgrove , Genelle-Marie S. Walker , Karina D. Silva , Kailee Nunez , Karina Alejos , Makayla Joseph , Justin R. Wright , Brittney McMullen , Regina Lamendella , Lisa Y. Maeng
Background
Previous studies have shown that fear extinction memory and the gut microbiome are impacted by ovarian hormones. Elevated 17β-estradiol (E2) levels during fear extinction learning have been shown to enhance fear extinction recall 24 hours later. In this study, we concurrently examined the long-term maintenance of this facilitation and the role of the gut microbiome as a potential mediator.
Methods
Naturally cycling adult female Sprague Dawley rats underwent an auditory-cued fear conditioning/extinction paradigm, during which the estrous cycle was tracked and fecal samples were collected. Habituation and conditioning took place when the rats were in estrus on day 1. On day 2, rats were administered either a sesame oil vehicle (n = 24) or E2 (15 μg/kg) (n = 25) before extinction training. Recent recall took place 24 hours after extinction training, and remote recall took place 1 to 2 weeks after extinction training (vehicle n = 13, E2 n = 12).
Results
E2-treated rats showed significantly lower freezing behavior compared with vehicle-treated rats during recent recall, but not remote recall. Gut bacterial analysis using 16S ribosomal RNA sequencing revealed unique enrichment of estrogen-regulating and anxiety-related bacterial families during remote recall.
Conclusions
The current data suggest that E2-enhanced fear extinction consolidation may be linked to alterations in gut microbiome composition. These findings may reveal a novel potential target for anxiety and other fear-based psychiatric disorders.
{"title":"Acute 17β-Estradiol Administration Enhances Fear Extinction Memory and Alters Gut Microbiota in Female Rats","authors":"Cassandra E. Hartsgrove , Genelle-Marie S. Walker , Karina D. Silva , Kailee Nunez , Karina Alejos , Makayla Joseph , Justin R. Wright , Brittney McMullen , Regina Lamendella , Lisa Y. Maeng","doi":"10.1016/j.bpsgos.2025.100620","DOIUrl":"10.1016/j.bpsgos.2025.100620","url":null,"abstract":"<div><h3>Background</h3><div>Previous studies have shown that fear extinction memory and the gut microbiome are impacted by ovarian hormones. Elevated 17β-estradiol (E2) levels during fear extinction learning have been shown to enhance fear extinction recall 24 hours later. In this study, we concurrently examined the long-term maintenance of this facilitation and the role of the gut microbiome as a potential mediator.</div></div><div><h3>Methods</h3><div>Naturally cycling adult female Sprague Dawley rats underwent an auditory-cued fear conditioning/extinction paradigm, during which the estrous cycle was tracked and fecal samples were collected. Habituation and conditioning took place when the rats were in estrus on day 1. On day 2, rats were administered either a sesame oil vehicle (<em>n</em> = 24) or E2 (15 μg/kg) (<em>n</em> = 25) before extinction training. Recent recall took place 24 hours after extinction training, and remote recall took place 1 to 2 weeks after extinction training (vehicle <em>n</em> = 13, E2 <em>n</em> = 12).</div></div><div><h3>Results</h3><div>E2-treated rats showed significantly lower freezing behavior compared with vehicle-treated rats during recent recall, but not remote recall. Gut bacterial analysis using 16S ribosomal RNA sequencing revealed unique enrichment of estrogen-regulating and anxiety-related bacterial families during remote recall.</div></div><div><h3>Conclusions</h3><div>The current data suggest that E2-enhanced fear extinction consolidation may be linked to alterations in gut microbiome composition. These findings may reveal a novel potential target for anxiety and other fear-based psychiatric disorders.</div></div>","PeriodicalId":72373,"journal":{"name":"Biological psychiatry global open science","volume":"6 1","pages":"Article 100620"},"PeriodicalIF":3.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145520848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-09-02DOI: 10.1016/j.bpsgos.2025.100604
Slavina B. Goleva , Costin Leu , Yen-Chen Anne Feng , David Burstein , Sanan Venkatesh , Rebecca Birnbaum , Veera M. Rajagopal , Peter Straub , Jakob Christensen , Jocelyn F. Bautista , Robyn M. Busch , Imad M. Najm , Jakob Grove , Anders D. Børglum , Georgios Voloudakis , Panos Roussos , Jordan Smoller , Dennis Lal , Lea K. Davis
Background
Functional seizures (FS) are paroxysmal episodes that phenotypically resemble epileptic seizures but are not associated with brain epileptiform discharges; they are also known as psychogenic nonepileptic seizures. The exact etiology and pathophysiology of FS is unknown; however, trauma and stress-related disorders are known risk factors.
Methods
We used a validated algorithm applied to electronic health records to identify individuals with FS in 6 international biobanks and hospital sites. We conducted a multisite FS genome-wide association study (GWAS) meta-analysis, including 10,910 FS cases (9040 predicted European ancestry [EA] and 1870 predicted African ancestry [AA]) and 664,500 (561,150 EA and 103,350 AA) control participants.
Results
The EA meta-analysis identified significant single nucleotide polymorphism–based heritability on the liability scale of 2.21% (SE = 0.015%, p = 10−3; assumed FS prevalence = 0.14%), but no genome-wide significant loci. Nominal associations emerged from the EA GWAS within 16q23.3 (CDH13 intronic variant rs8056064, effect allele = A, z = −4.762, p = 1.92 × 10−6) and from the AA GWAS within 17q21.2 (rs34380994, effect allele = T, z = 5.28, p = 1.32 × 10−7). Significantly associated gene sets included magnesium ion transport, mitochondrial membrane complexes, and RNA polymerase II preinitiation complex assembly (Bonferroni-corrected p values = .0095, .012, and .03, respectively). MAGMA gene property analysis for tissue specificity showed significant enrichment of FS-associated genes within cerebellum-expressed genes (beta = 0.019, SE = 0.0059, p = 7.1 × 10−3).
Conclusions
To our knowledge, this is the first GWAS of FS, and our results support a genetic basis of FS. Future large-scale genetic research studies are needed to corroborate these findings and identify genetic variants associated with FS.
背景:功能性发作(FS)是一种发作性发作,在表型上与癫痫发作相似,但与脑癫痫样放电无关;它们也被称为心因性非癫痫性发作。FS的确切病因和病理生理尚不清楚;然而,创伤和压力相关的疾病是已知的危险因素。方法采用电子健康记录验证算法对6家国际生物库和医院的FS患者进行识别。我们进行了一项多位点FS全基因组关联研究(GWAS)荟萃分析,包括10,910例FS病例(9040例预测欧洲血统[EA], 1870例预测非洲血统[AA])和664,500例(561,150例预测EA和103,350例预测AA)对照受试者。结果EA荟萃分析发现,基于单核苷酸多态性的显著遗传率为2.21% (SE = 0.015%, p = 10−3;假设FS患病率= 0.14%),但没有全基因组显著位点。EA GWAS在16q23.3内(CDH13内含子变异rs8056064,效应等位基因= A, z = - 4.762, p = 1.92 × 10−6)和AA GWAS在17q21.2内(rs34380994,效应等位基因= T, z = 5.28, p = 1.32 × 10−7)产生名义关联。显著相关的基因集包括镁离子转运、线粒体膜复合物和RNA聚合酶II起始前复合物组装(bonferroni校正p值= 0.0095,)。012,和。分别为03)。MAGMA组织特异性基因特性分析显示,小脑表达基因中fs相关基因显著富集(β = 0.019, SE = 0.0059, p = 7.1 × 10−3)。结论据我们所知,这是FS的第一个GWAS,我们的结果支持FS的遗传基础。未来需要大规模的遗传研究来证实这些发现,并确定与FS相关的遗传变异。
{"title":"Multisite, Multiancestry Genome-Wide Association Study Meta-Analysis of Functional Seizure Disorder in a Hospital Sample of 675,680 Patients","authors":"Slavina B. Goleva , Costin Leu , Yen-Chen Anne Feng , David Burstein , Sanan Venkatesh , Rebecca Birnbaum , Veera M. Rajagopal , Peter Straub , Jakob Christensen , Jocelyn F. Bautista , Robyn M. Busch , Imad M. Najm , Jakob Grove , Anders D. Børglum , Georgios Voloudakis , Panos Roussos , Jordan Smoller , Dennis Lal , Lea K. Davis","doi":"10.1016/j.bpsgos.2025.100604","DOIUrl":"10.1016/j.bpsgos.2025.100604","url":null,"abstract":"<div><h3>Background</h3><div>Functional seizures (FS) are paroxysmal episodes that phenotypically resemble epileptic seizures but are not associated with brain epileptiform discharges; they are also known as psychogenic nonepileptic seizures. The exact etiology and pathophysiology of FS is unknown; however, trauma and stress-related disorders are known risk factors.</div></div><div><h3>Methods</h3><div>We used a validated algorithm applied to electronic health records to identify individuals with FS in 6 international biobanks and hospital sites. We conducted a multisite FS genome-wide association study (GWAS) meta-analysis, including 10,910 FS cases (9040 predicted European ancestry [EA] and 1870 predicted African ancestry [AA]) and 664,500 (561,150 EA and 103,350 AA) control participants.</div></div><div><h3>Results</h3><div>The EA meta-analysis identified significant single nucleotide polymorphism–based heritability on the liability scale of 2.21% (SE = 0.015%, <em>p</em> = 10<sup>−3</sup>; assumed FS prevalence = 0.14%), but no genome-wide significant loci. Nominal associations emerged from the EA GWAS within 16q23.3 (<em>CDH13</em> intronic variant rs8056064, effect allele = A, <em>z</em> = −4.762, <em>p</em> = 1.92 × 10<sup>−6</sup>) and from the AA GWAS within 17q21.2 (rs34380994, effect allele = T, <em>z</em> = 5.28, <em>p</em> = 1.32 × 10<sup>−7</sup>). Significantly associated gene sets included magnesium ion transport, mitochondrial membrane complexes, and RNA polymerase II preinitiation complex assembly (Bonferroni-corrected <em>p</em> values = .0095, .012, and .03, respectively). MAGMA gene property analysis for tissue specificity showed significant enrichment of FS-associated genes within cerebellum-expressed genes (beta = 0.019, SE = 0.0059, <em>p</em> = 7.1 × 10<sup>−3</sup>).</div></div><div><h3>Conclusions</h3><div>To our knowledge, this is the first GWAS of FS, and our results support a genetic basis of FS. Future large-scale genetic research studies are needed to corroborate these findings and identify genetic variants associated with FS.</div></div>","PeriodicalId":72373,"journal":{"name":"Biological psychiatry global open science","volume":"6 1","pages":"Article 100604"},"PeriodicalIF":3.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145419192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-09-17DOI: 10.1016/j.bpsgos.2025.100615
Olga D. Boer , Hanan El Marroun , Doga Ultanir , Ingmar H.A. Franken
Background
Altered electrophysiological error processing, measured via the error-related negativity (ERN), error-related positivity (Pe), and midfrontal theta power (FM-theta), has been associated with problematic alcohol use and alcohol dependence in clinical populations. However, large-scale studies focusing on adolescent use in the general population are scarce. Moreover, the extent to which potential confounding factors shape the relationship between brain activity and alcohol use remains unclear.
Methods
In the current study, we examined the relationship between adolescent alcohol use and electrophysiological markers of error processing (ERN, Pe, and FM-theta) in a large adolescent sample drawn from a population-based cohort (N = 1525, 806 female, mean age = 18.4). Alcohol use variables included initiation, age at initiation, recent alcohol use quantity, and recent binge drinking frequency. Confounders included sex, IQ, socioeconomic factors, and alcohol-related risk factors such as prenatal alcohol and tobacco exposure or a parental history of substance use disorder.
Results
Linear regression analyses showed that smaller absolute ERN amplitude (indicating reduced implicit error processing) was associated with risk factors for alcohol use disorder, including early alcohol use initiation and higher binge drinking frequency. Surprisingly, higher binge drinking frequency was also associated with larger Pe amplitude. These findings remained present after adjustment for confounding variables and were not moderated by sex.
Conclusions
These findings show an important link between prevalent alcohol use behaviors and altered electrophysiological markers of error processing, representing a promising step forward in using large-scale electroencephalography for brain-alcohol use research and its clinical implications.
{"title":"Adolescent Risky Alcohol Use Is Associated With Electrophysiological Markers of Error Processing: Findings From a Large Cohort Study","authors":"Olga D. Boer , Hanan El Marroun , Doga Ultanir , Ingmar H.A. Franken","doi":"10.1016/j.bpsgos.2025.100615","DOIUrl":"10.1016/j.bpsgos.2025.100615","url":null,"abstract":"<div><h3>Background</h3><div>Altered electrophysiological error processing, measured via the error-related negativity (ERN), error-related positivity (Pe), and midfrontal theta power (FM-theta), has been associated with problematic alcohol use and alcohol dependence in clinical populations. However, large-scale studies focusing on adolescent use in the general population are scarce. Moreover, the extent to which potential confounding factors shape the relationship between brain activity and alcohol use remains unclear.</div></div><div><h3>Methods</h3><div>In the current study, we examined the relationship between adolescent alcohol use and electrophysiological markers of error processing (ERN, Pe, and FM-theta) in a large adolescent sample drawn from a population-based cohort (<em>N</em> = 1525, 806 female, mean age = 18.4). Alcohol use variables included initiation, age at initiation, recent alcohol use quantity, and recent binge drinking frequency. Confounders included sex, IQ, socioeconomic factors, and alcohol-related risk factors such as prenatal alcohol and tobacco exposure or a parental history of substance use disorder.</div></div><div><h3>Results</h3><div>Linear regression analyses showed that smaller absolute ERN amplitude (indicating reduced implicit error processing) was associated with risk factors for alcohol use disorder, including early alcohol use initiation and higher binge drinking frequency. Surprisingly, higher binge drinking frequency was also associated with larger Pe amplitude. These findings remained present after adjustment for confounding variables and were not moderated by sex.</div></div><div><h3>Conclusions</h3><div>These findings show an important link between prevalent alcohol use behaviors and altered electrophysiological markers of error processing, representing a promising step forward in using large-scale electroencephalography for brain-alcohol use research and its clinical implications.</div></div>","PeriodicalId":72373,"journal":{"name":"Biological psychiatry global open science","volume":"6 1","pages":"Article 100615"},"PeriodicalIF":3.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145365069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}